A detailed history of Verum Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Verum Partners LLC holds 1,359 shares of AMGN stock, worth $361,426. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,359
Previous 1,341 1.34%
Holding current value
$361,426
Previous $419 Million 4.52%
% of portfolio
0.13%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$309.38 - $337.38 $5,568 - $6,072
18 Added 1.34%
1,359 $438 Million
Q2 2024

Jul 15, 2024

BUY
$262.75 - $319.31 $7,094 - $8,621
27 Added 2.05%
1,341 $419 Million
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $4,839 - $5,842
18 Added 1.39%
1,314 $374 Million
Q4 2023

Jan 18, 2024

SELL
$255.7 - $288.46 $767 - $865
-3 Reduced 0.23%
1,296 $373 Million
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $179,948 - $223,411
-823 Reduced 38.78%
1,299 $349 Million
Q2 2023

Jul 24, 2023

BUY
$214.27 - $253.37 $454,680 - $537,651
2,122 New
2,122 $471 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $142B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Verum Partners LLC Portfolio

Follow Verum Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verum Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verum Partners LLC with notifications on news.